Jens Bjørheim
Chief Tech/Sci/R&D Officer bei ULTIMOVACS ASA
Profil
Jens Bjørheim is currently the Chief Medical Officer at Ultimovacs ASA. Previously, he worked as the Medical Director at Pronova BioPharma ASA from 2006 to 2008 and as the Senior Medical Director-Oncology at AstraZeneca A from 2013 to 2016.
He holds two doctorate degrees, one from the University of Oslo in 1999 and another from the same university in 2003.
Aktive Positionen von Jens Bjørheim
| Unternehmen | Position | Beginn |
|---|---|---|
| ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Jens Bjørheim
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01.01.2016 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Tech/Sci/R&D Officer | 01.01.2008 |
Ausbildung von Jens Bjørheim
| University of Oslo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
